home/actions/themes/eu-china-procurement-market-access-reciprocity

EU-China public-procurement market-access reciprocity cycle

Tit-for-tat restriction of public-procurement market access between the EU and China, running on a distinct legal track from the broader FSR/TIB dispute. Triggered by the EU's first-ever use of its International Procurement Instrument (IPI) on 20 June 2025 to exclude Chinese medical-device firms from EU tenders above EUR 5m; China's Ministry of Finance responded with Caiku [2025] No. 19, excluding EU firms (ex-China-invested subsidiaries) from Chinese medical-device procurement above CNY 45m and capping EU-import content for other bidders at 50%. Tracks further escalation or de-escalation in either direction.

2 actionspeak severity 4· 2 countries targeted· 2 sectors· 2 issuers· avg sev 3.5· span 1mo

view:default · timeline + chronology retaliation forecast

2 issuers act on 2 targets · EU leads with 1 action (severity 4)

Click a country to isolate · 2 edges shown

Severity over time — theme regime evolution2 actions, arcs show in-theme responds_to links

Each dot = one action; vertical position is severity (1-5), horizontal position is announced_date. Color coded by issuer (US blue, CN red, EU amber, GB darker blue, JP pink, KR emerald, NL orange, ID lime, others gray). Dashed arcs connect explicit responds_to pairs within this theme. Hover any element for the action title + date.

A young, narrow-track reciprocity cycle distinct from the broader EU FSR/TIB dispute (see western-industrial-policy-stack for the TIB determination). The IPI is a different legal instrument from the FSR, invoked here for the first time, and China's countermeasure mirrors its structure closely (threshold + carve-out for locally invested subsidiaries + content cap for remaining bidders).

Watch for: EU IPI designations expanding beyond medical devices; China lowering its CNY 45m threshold or extending the exclusion model to other IPI-adjacent sectors; and whether this track merges with or stays separate from the FSR/TIB escalation chain.